as of 12-12-2025 3:44pm EST
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SANTA CLARA |
| Market Cap: | 606.1M | IPO Year: | 2018 |
| Target Price: | $24.33 | AVG Volume (30 days): | 593.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.51 | EPS Growth: | N/A |
| 52 Week Low/High: | $12.49 - $20.05 | Next Earning Date: | 11-10-2025 |
| Revenue: | $193,578,000 | Revenue Growth: | 23.27% |
| Revenue Growth (this year): | 21.44% | Revenue Growth (next year): | 15.30% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Director
Avg Cost/Share
$19.33
Shares
20,000
Total Value
$386,594.00
Owned After
10,307
Chief Financial Officer
Avg Cost/Share
$20.00
Shares
100
Total Value
$2,000.00
Owned After
203,773
SEC Form 4
SVP, Ops & Adm/Chief Legal Ofr
Avg Cost/Share
$20.00
Shares
400
Total Value
$8,000.00
Owned After
251,496
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$20.01
Shares
1,200
Total Value
$24,015.96
Owned After
203,773
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$17.70
Shares
5,411
Total Value
$95,762.80
Owned After
351,319
SEC Form 4
President, Commercial Ops
Avg Cost/Share
$17.43
Shares
3,833
Total Value
$66,832.02
Owned After
270,270
Chief Financial Officer
Avg Cost/Share
$17.42
Shares
3,460
Total Value
$60,297.12
Owned After
203,773
Chief Executive Officer
Avg Cost/Share
$17.43
Shares
11,341
Total Value
$197,622.36
Owned After
351,319
SVP, Ops & Adm/Chief Legal Ofr
Avg Cost/Share
$17.41
Shares
3,328
Total Value
$57,933.66
Owned After
251,496
Chief Financial Officer
Avg Cost/Share
$18.33
Shares
2,601
Total Value
$47,684.91
Owned After
203,773
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| DUNN JEFFREY W | SIBN | Director | Dec 8, 2025 | Sell | $19.33 | 20,000 | $386,594.00 | 10,307 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Nov 25, 2025 | Sell | $20.00 | 100 | $2,000.00 | 203,773 | |
| Pisetsky Michael A | SIBN | SVP, Ops & Adm/Chief Legal Ofr | Nov 24, 2025 | Sell | $20.00 | 400 | $8,000.00 | 251,496 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Nov 21, 2025 | Sell | $20.01 | 1,200 | $24,015.96 | 203,773 | |
| FRANCIS LAURA | SIBN | Chief Executive Officer | Nov 18, 2025 | Sell | $17.70 | 5,411 | $95,762.80 | 351,319 | |
| RECUPERO ANTHONY J | SIBN | President, Commercial Ops | Nov 17, 2025 | Sell | $17.43 | 3,833 | $66,832.02 | 270,270 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Nov 17, 2025 | Sell | $17.42 | 3,460 | $60,297.12 | 203,773 | |
| FRANCIS LAURA | SIBN | Chief Executive Officer | Nov 17, 2025 | Sell | $17.43 | 11,341 | $197,622.36 | 351,319 | |
| Pisetsky Michael A | SIBN | SVP, Ops & Adm/Chief Legal Ofr | Nov 17, 2025 | Sell | $17.41 | 3,328 | $57,933.66 | 251,496 | |
| Maheshwari Anshul | SIBN | Chief Financial Officer | Nov 11, 2025 | Sell | $18.33 | 2,601 | $47,684.91 | 203,773 |
See how SIBN stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SIBN SI-BONE Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.